Showing results (2291-2300 of 5,502) with videos related to

Sort By:
Pageof 551
Inflammatory Bowel Diseases|March 13, 2018
Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis PatientsCarlos Zamora, Elisabet Canto, Juan C Nieto, et al.
Inflammatory Bowel Diseases|January 29, 2019
Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive PatientsDaniela Leone, Daniela Gilardi, Bianca E Corrò, et al.
Inflammatory Bowel Diseases|September 26, 2020
Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic TherapyJacob A Kurowski, Jean-Paul Achkar, Rishi Gupta, et al.
Inflammatory Bowel Diseases|March 19, 2020
The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel DiseaseLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
Inflammatory Bowel Diseases|December 29, 2019
Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative ColitisDavid Kevans, Richard Kirsch, Callum Dargavel, et al.
Inflammatory Bowel Diseases|January 3, 2020
Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-κB Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine ColitisJung Won Lee, Soung-Min Lee, Jaeyoung Chun, et al.
Inflammatory Bowel Diseases|March 15, 2020
Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE)Mark T Osterman, Frank I Scott, Franz F Fogt, et al.
Inflammatory Bowel Diseases|August 30, 2020
Clinical Variables Associated With Statural Growth in Pediatric Crohn's Disease Differ by Sex (The Growth Study)Neera Gupta, Robert H Lustig, Howard Andrews, et al.
Inflammatory Bowel Diseases|August 30, 2020
Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn DiseaseAhmad Albshesh, Bella Ungar, Shomron Ben-Horin, et al.
Inflammatory Bowel Diseases|October 22, 2020
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel DiseasesKristin E Burke, Bharati Kochar, Jessica R Allegretti, et al.
Pageof 551